Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Vaccination

Showing 12 out of 55 results
A microscope image of cervical cells that have changed shape and size because of HPV infection. Most of the cells are blue, but some are pink or purple.

We funded the Cervical Cancer Elimination Planning Tool, which countries around the world can use to find the best way for them to use screening, vaccination and treatment to stop cervical cancer. We funded the Cervical Cancer Elimination Planning Tool, which countries around the world can use to find the best way for them to use screening, vaccination and treatment to stop cervical cancer.

by Amal Iman | News | 19 June 2025

19 June 2025

This entry is part 24 of 29 in the series That Cancer Conversation
This entry is part 23 of 29 in the series That Cancer Conversation
Head shots of Dr Lian Ni Lee, Sânziana Foia and Professor Christine Harrison

For International Women's Day 2025, we're celebrating three inspirational women and the contributions they have made to cancer research For International Women's Day 2025, we're celebrating three inspirational women and the contributions they have made to cancer research

by Amy Warnock | In depth | 8 March 2025

8 March 2025

vaccine vials on a production line with a gloved hand reaching to grab one of them

Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer. Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

by Sophie Wedekind | News | 4 October 2024

4 October 2024

A medical professional drawing a dose of a vaccine from a vial with a syringe

LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types. LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types.

by Tim Gunn | News | 10 September 2024

10 September 2024

A young Nepalese girl standing among a group of women

Through the International Cancer Prevention programme, we’re helping to expand access to HPV vaccination for adolescent girls in low and middle income countries, to prevent cervical cancer. Through the International Cancer Prevention programme, we’re helping to expand access to HPV vaccination for adolescent girls in low and middle income countries, to prevent cervical cancer.

by Elle Pearson | News | 24 June 2024

24 June 2024

Squamous epithelial cells of human cervix under the microscope view.
  • Science & Technology
  • Health & Medicine

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

by Jacob Smith | In depth | 17 June 2024

17 June 2024

An unrecognisable young girl receiving a vaccination.

The HPV vaccine is preventing the highest number of cervical cancer cases in the most deprived groups in England. The HPV vaccine is preventing the highest number of cervical cancer cases in the most deprived groups in England.

by Tim Gunn | News | 16 May 2024

16 May 2024

Vaccine vial and needle

Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials

by Iain Foulkes | Opinion | 26 April 2024

26 April 2024